You are here

Home » News

Health

Is downsizing right for you?

Active aging with Mennonite Home Communities of Ohio
Posted by Fred Steiner on Thursday, September 17, 2020

Downsizing is a hot topic among older adults. In a recent conversation via the Empower'd Aging Group on Facebook, I queried the 'ASK ME ANYTHING' expert, Thomesa Lydon, founder of Lydon Senior Pathways, questions about relocation and downsizing. 

Question: "Thomesa, what's the first piece of advice you give someone when they hope to downsize?"

Answer - "First create a plan that includes how you see yourself living in the next 10, 20 or even 30 years. Know your financial picture which will clearly illustrate your options -- what you can afford." 

»

First injectable for cellulite approved

FDA approves Qwo (collagenase clostridium histolyticum-aaes) for cellulite
Posted by Fred Steiner on Saturday, September 12, 2020

This article provided by ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has approved the first injectable medication for cellulite.

This medication is called Qwo (collagenase clostridium histolyticum-aaes). The FDA approved it to treat adult women with moderate to severe cellulite in the buttocks.

Qwo comes in the form of an injection and is given under the skin (subcutaneously) of each buttock by your health care provider.

You may receive up to 12 injections per treatment area. Each treatment visit may include up to two treatment areas.

These injections will be given 21 days apart for three treatment visits.

»

Approved: Saliva-based COVID-19 test

FDA approves Yale's new saliva-based COVID-19 test
Posted by Fred Steiner on Saturday, September 5, 2020

This column is provided by the ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a saliva test for SARS-CoV-2, the virus that causes COVID-19 infection.

This approval was granted to the Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test.

The SalivaDirect test is a new method for processing saliva samples. Because the test is saliva-based and does not need reagents (critical test components for other tests that have been prone to shortages in the past), this new approval may allow for increased COVID-19 testing, according to the FDA.

»

Kidney stone prevention

Everything you need to know about kidney stones
Posted by Anne Pannabecke... on Saturday, August 29, 2020

This column is provided by ONU HealthWise Pharmacy.

Kidney stones may be small, but they can pack a lot of pain. Read on to find out how you can reduce your chance of developing kidney stones.

Kidney stones form in the kidneys and can cause discomfort and pain. They can be small, but large ones can become stuck in the urinary tract, blocking the flow of urine and causing intense pain.

In some cases, kidney stones will pass on their own. However, in other situations, medical treatment may be necessary. The following are signs of kidney stones that require a doctor's attention:

Extreme pain in your back or side (Pain tends to remain and not go away.)

»

Multi-condition nasal spray recalled

Manufacturers of desmopressin nasal spray recalls all lots
Posted by Anne Pannabecke... on Saturday, August 22, 2020

This column is provided by Ohio Northern University HealthWise Pharmacy.

All lots of Ferring Pharmaceuticals' multi-condition nasal spray are being recalled.

The problem? These lots have higher-than-specified amounts of desmopressin.

Higher amounts of desmopressin can lead to abnormally low levels of sodium in the blood. And very low levels of sodium in the blood can lead to dangerous health events, such as seizures, coma and even death.

»

Nasal spray for depression gets new approved use

FDA approves Spravato (esketamine) to treat major depressive disorder
Posted by Fred Steiner on Saturday, August 15, 2020

This column provided by ONU HealthWise Pharmacy.
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.

Approved for treatment-resistant depression (TRD) in March of 2019, esketamine is now approved to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior.

»

Pages